These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 23765923)
1. MicroRNA-200C and -150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1. Luo Z; Wen G; Wang G; Pu X; Ye S; Xu Q; Wang W; Xiao Q Stem Cells; 2013 Sep; 31(9):1749-62. PubMed ID: 23765923 [TBL] [Abstract][Full Text] [Related]
2. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544 [TBL] [Abstract][Full Text] [Related]
3. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
4. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Magenta A; Cencioni C; Fasanaro P; Zaccagnini G; Greco S; Sarra-Ferraris G; Antonini A; Martelli F; Capogrossi MC Cell Death Differ; 2011 Oct; 18(10):1628-39. PubMed ID: 21527937 [TBL] [Abstract][Full Text] [Related]
5. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Howe EN; Cochrane DR; Richer JK Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518 [TBL] [Abstract][Full Text] [Related]
6. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844 [TBL] [Abstract][Full Text] [Related]
7. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma. Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572 [TBL] [Abstract][Full Text] [Related]
8. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528 [TBL] [Abstract][Full Text] [Related]
9. The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression. Zhou X; Wang Y; Shan B; Han J; Zhu H; Lv Y; Fan X; Sang M; Liu XD; Liu W Med Oncol; 2015 Jan; 32(1):428. PubMed ID: 25502084 [TBL] [Abstract][Full Text] [Related]
10. Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Kane NM; Howard L; Descamps B; Meloni M; McClure J; Lu R; McCahill A; Breen C; Mackenzie RM; Delles C; Mountford JC; Milligan G; Emanueli C; Baker AH Stem Cells; 2012 Apr; 30(4):643-54. PubMed ID: 22232059 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Hurteau GJ; Carlson JA; Spivack SD; Brock GJ Cancer Res; 2007 Sep; 67(17):7972-6. PubMed ID: 17804704 [TBL] [Abstract][Full Text] [Related]
12. Coordinated regulation of β-tubulin isotypes and epithelial-to-mesenchymal transition protein ZEB1 in breast cancer cells. Lobert S; Graichen ME; Morris K Biochemistry; 2013 Aug; 52(32):5482-90. PubMed ID: 23869586 [TBL] [Abstract][Full Text] [Related]
13. miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. Chuang TD; Panda H; Luo X; Chegini N Endocr Relat Cancer; 2012 Aug; 19(4):541-56. PubMed ID: 22685266 [TBL] [Abstract][Full Text] [Related]
14. miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling. Chen Y; Sun Y; Chen L; Xu X; Zhang X; Wang B; Min L; Liu W Mol Med Rep; 2013 May; 7(5):1579-84. PubMed ID: 23546450 [TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanism of MicroRNA-200c Regulating Transforming Growth Factor-β (TGF-β)/SMAD Family Member 3 (SMAD3) Pathway by Targeting Zinc Finger E-Box Binding Homeobox 1 (ZEB1) in Hypospadias in Rats. Qian C; Dang X; Wang X; Xu W; Pang G; Chen Y; Liu C Med Sci Monit; 2016 Oct; 22():4073-4081. PubMed ID: 27794206 [TBL] [Abstract][Full Text] [Related]
16. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752 [TBL] [Abstract][Full Text] [Related]
17. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma. Kurata A; Yamada M; Ohno SI; Inoue S; Hashimoto H; Fujita K; Takanashi M; Kuroda M Oncol Rep; 2018 Jan; 39(1):91-100. PubMed ID: 29138864 [TBL] [Abstract][Full Text] [Related]
18. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305 [TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA-1604 Orchestrates Neural Differentiation through the miR-200c/ZEB Axis. Weng R; Lu C; Liu X; Li G; Lan Y; Qiao J; Bai M; Wang Z; Guo X; Ye D; Jiapaer Z; Yang Y; Xia C; Wang G; Kang J Stem Cells; 2018 Mar; 36(3):325-336. PubMed ID: 29205638 [TBL] [Abstract][Full Text] [Related]
20. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism. Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]